Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Moving beyond Titers. | Vaccines (Basel) | 2022 | 35632439 | PubTator, text mining | PubMed |
| High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. | Genes (Basel) | 2022 | 35627262 | PubTator, text mining | PubMed |
| A Single-Center Experience on HLA Typing with 11 Loci Next Generation Sequencing in Korean Patients with Hematologic Disease. | Diagnostics (Basel) | 2022 | 35626230 | PubTator, text mining | PubMed |
| Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids. | Biomedicines | 2022 | 35625761 | PubTator, text mining | PubMed |
| Unexpected cure of a toxic nodule in a multinodular goiter induced by immune checkpoint inhibitors: a case report. | Eur Thyroid J | 2022 | 35621352 | PubTator, text mining | PubMed |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. | iScience | 2022 | 35620424 | PubTator, text mining | PubMed |
| Immune disease risk variants regulate gene expression dynamics during CD4+ T cell activation. | Nat Genet | 2022 | 35618845 | PubTator, text mining | PubMed |
| ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma. | J Immunol Res | 2022 | 35615532 | PubTator, text mining | PubMed |
| Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches. | Front Immunol | 2022 | 35603198 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma. | Front Immunol | 2022 | 35603163 | PubTator, text mining | PubMed |
| Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response. | Recent Pat Anticancer Drug Discov | 2022 | 35593340 | PubTator, text mining | PubMed |
| Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy. | Biomed Res Int | 2022 | 35592524 | PubTator, text mining | PubMed |
| Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk. | Arthritis Rheumatol | 2022 | 35583917 | PubTator, text mining | PubMed |
| Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination. | Hum Vaccin Immunother | 2022 | 35583472 | PubTator, text mining | PubMed |
| ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer. | Sci Rep | 2022 | 35581263 | PubTator, text mining | PubMed |
| Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients. | J Clin Lab Anal | 2022 | 35576501 | PubTator, text mining | PubMed |
| COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma. | Front Oncol | 2022 | 35574298 | PubTator, text mining | PubMed |
| Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC. | Front Immunol | 2022 | 35572559 | PubTator, text mining | PubMed |
| Human Leukocyte Antigens in Pregnancy and Preeclampsia. | Front Genet | 2022 | 35571013 | PubTator, text mining | PubMed |
| The molecular characteristics of gastric cancer patients living in Qinghai-Tibetan Plateau. | BMC Gastroenterol | 2022 | 35568828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=43